Ignite Creation Date:
2024-05-06 @ 3:51 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04770545
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-26
First Post:
2021-02-23
Brief Title:
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan APL-2 in Subjects With Geographic Atrophy Secondary to AMD
Sponsor:
Apellis Pharmaceuticals Inc
Organization:
Apellis Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-04
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-23
First Submit QC Date:
February 23 2021
Study First Post Date:
2021-02-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-24
Last Update Post Date:
2024-06-26
Last Update Post Date Type:
ACTUAL